Want to track TXMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TherapeuticsMD, Inc. (TXMD) Statistics
Valuation metrics
Market Cap 23.15M
Enterprise value 21.26M
Trailing P/E (ttm) 133.77
Forward P/E 5.69
PEG ratio -0.06
Price/Sales (ttm) 7.11
Price/Book (mrq) 0.88
Enterprise Value/Revenue 6.34
Enterprise Value/EBITDA -6.2
Overview
Shares outstanding 11.57M
Float 9.49M
Shares short 56.77K
% Held by insiders 0.07%
% Held by institutions 0.3%
Average volume (10 days) 31.96K
Average volume (90 days) 43.86K
Price summary
52-Week low 0.99
52-Week high 2.95
Beta 0.56
50-Day moving average 2.1
200-Day moving average 2.16
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 10 Jun 2008
Ex-Dividend Date 6 Jun 2008
Last split factor 1:50
Last split Date 9 May 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.05%
Operating margin -1.12%
Operational effectiveness
Return on assets 0%
Return on equity 0.01%
Income Statement
Revenue (ttm) 3.35M
Revenue per share (ttm) 0.29
Quarterly revenue growth (yoy) 0.84%
Gross profit (ttm) 3.35M
EBITDA -1.41M
Net income to common (ttm) 86K
Diluted EPS (ttm) 0.02
Quarterly earnings growth (yoy) 0.34%
Balance Sheet
Total cash (mrq) 8.42M
Total cash per share (mrq) 0.73
Total debt (mrq) 4.82M
Total Debt/Equity (mrq) 0.22
Current ratio (mrq) 3.11%
Book value per share (mrq) 2.33
Cash Flow
Cash flow statement 2.67M
Levered free cash flow (LFCF) 1.33M
